Loading...
Search
AI Chat
AI Strategies
Products
Markets
News
Resources
Pricing
Home
Stock
CINGW
CINGW News & Events
-
Add to Watchlist
Trade CINGW
$
0.000
0.000
(
0.000%
)
At close
0.000
(
0.000%
)
Aft-market
ET
$
0.000
0.000
(
0.000%
)
At close
0.000
(
0.000%
)
Aft-market
ET
Overview
Forecast
Technical
Valuation
Financials
Earnings
Should I Buy
News
CINGW News
Cingulate's Top ADHD Candidate CTx-1301 Chosen for Podium Presentation at AACAP Annual Meeting
Oct 23 2025
Newsfilter
Cingulate Forms Exclusive Manufacturing Alliance with Bend Bio Sciences for Upcoming ADHD Treatment Commercialization
Sep 17 2025
Newsfilter
Cingulate Inc. Announces Financial Results for Q2 2025 and Shares Recent Developments
Aug 19 2025
Newsfilter
Cingulate Submits New Drug Application to FDA for Lead ADHD Asset CTx-1301
Aug 06 2025
Newsfilter
Cingulate Receives $4.3M Waiver from FDA Ahead of Imminent Filing for Marketing Approval of Lead ADHD Asset CTx-1301
Jul 29 2025
Newsfilter
FDA and Cingulate Aligned with Filing Requirements for New Drug Application for Lead ADHD Asset CTx-1301
May 14 2025
Newsfilter
Cingulate Inc. Reports First Quarter 2025 Financial Results and Provides an Updated Timeline of Key Developments for its lead ADHD and Anxiety Assets
May 08 2025
Newsfilter
Cingulate Receives $3 Million Grant from Private Foundation to Accelerate Development of Anxiety Asset CTx-2103 (buspirone)
Apr 09 2025
Newsfilter
Show More News
CINGW Events
No data
CINGW Monitor News
No data
CINGW Earnings Analysis
No Data
People Also Watch
